Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.05 USD | -5.41% | +11.99% | +6.66% |
Apr. 01 | Quince Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 26 | Transcript : Quince Therapeutics, Inc. - Special Call |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
+6.66% | 47.97M | |
+5.14% | 43.43B | |
+48.49% | 41.69B | |
+9.28% | 41.31B | |
-10.82% | 27.14B | |
+10.57% | 25.28B | |
-23.79% | 18.47B | |
+36.62% | 12.59B | |
+2.74% | 12.33B | |
+8.28% | 11.03B |
- Stock Market
- Equities
- QNCX Stock
- News Quince Therapeutics, Inc.
- Cortexyme to Buy Novosteo